Amicus Therapeutics
FOLD
$10.54
Share price
-1.59%
Change (1 day)
-8.27%
Change (1 year)
Categories
P/S ratio for Amicus Therapeutics (FOLD)
P/S ratio as of April 2024 (TTM): 7.80
According to Amicus Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.79589. At the end of 2023 the company had a P/S ratio of 10.4.
P/S ratio history for Amicus Therapeutics from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.4 | 0% |
| 2022 | 10.4 | -1.09% |
| 2021 | 10.5 | -54.33% |
| 2020 | 23.1 | 68.95% |
| 2019 | 13.7 | -31.34% |
| 2018 | 19.9 | -69.31% |
| 2017 | 64.8 | -54.59% |
| 2016 | 143 | |
| 2015 | N/A | -100% |
| 2014 | 650 | 61.89% |
| 2013 | 401 | 5453.47% |
| 2012 | 7.22 | 29.9% |
| 2011 | 5.56 | -96.84% |
| 2010 | 176 | 12477.63% |
| 2009 | 1.40 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | 16.6 | 113.51% | 🇩🇰 Denmark |
 Biogen BIIB | 2.99 | -61.71% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.21 | -71.71% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | 327 | 4,093.93% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | 3.47 | -55.52% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 7.15 | -8.23% | 🇺🇸 USA |